✦ LIBER ✦

Four year immunogenicity of the RTS,S/AS02A malaria vaccine in Mozambican children during a phase IIb trial

✍ Scribed by Pedro Aide; Carlota Dobaño; Jahit Sacarlal; John J. Aponte; Inácio Mandomando; Caterina Guinovart; Quique Bassat; Montse Renom; Laura Puyol; Eusebio Macete; Esperanza Herreros; Amanda Leach; Marie-Claude Dubois; Marie-Ange Demoitie; Marc Lievens; Johan Vekemans; Christian Loucq; W. Ripley Ballou; Joe Cohen; Pedro L. Alonso

Book ID: 116963652
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 365 KB
Volume: 29
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2011.03.041

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of the RTS,S/AS02A malaria vaccin

Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial

✍ Jahit Sacarlal; John J. Aponte; Pedro Aide; Inácio Mandomando; Quique Bassat; Ca 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 471 KB

Safety and immunogenicity of the RTS,S/A

Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique

✍ E. Macete; J. J. Aponte; C. Guinovart; J. Sacarlal; O. Ofori-Anyinam; I. Mandoma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 535 KB

Duration of protection with RTS,S/AS02A

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

✍ Pedro L Alonso; Jahit Sacarlal; John J Aponte; Amanda Leach; Eusebio Macete; Ped 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 119 KB

Safety of the RTS,S/AS02D candidate mala

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

✍ John J Aponte; Pedro Aide; Montse Renom; Inacio Mandomando; Quique Bassat; Jahit 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 192 KB

Randomized, controlled trial of the long

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02Dmalaria vaccine in infants living in a malaria-endemic region

✍ Salim Abdulla, Nahya Salim, Francisca Machera, Richard Kamata, Omar Juma… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 243 KB

A phase I/IIa safety, immunogenicity, an

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults

✍ Kent E. Kester; Denise A. McKinney; Nadia Tornieporth; Christian F. Ockenhouse; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 174 KB